The in vivo anti-tumor effect of curcumin derivative (2 E,6 E)-2,6-bis(4-hydroxy-3-methoxybenzylidene)cyclohexanone (BHMC) on 4T1 breast cancer cells
Curcumin is one of the promising natural products extracted from the rhizomes of curcuma longa and has been extensively investigated by researchers to explore its potential as a chemopreventive and therapeutic agent against several chronic diseases. To further enhance the cytotoxic potential of curc...
Saved in:
Main Authors: | Razak, Nursyamirah Abd, Akhtar, M. Nadeem, Abu, Nadiah, Wan, Yong Ho, Sheau, Wei Tan, Zareen, Seema, Taj-ud-din, Saiful Nizam, Long, Kamariah, Alitheen, Noorjahan Banu, Swee, Keong Yeap |
---|---|
Format: | Article |
Language: | English |
Published: |
Royal Society of Chemistry
2017
|
Online Access: | http://psasir.upm.edu.my/id/eprint/63554/1/The%20in%20vivo%20anti-tumor%20effect%20of%20curcumin%20derivative%20%282E%2C6E%29-2%2C6-bis%284-hydroxy-3-methoxybenzylidene%29cyclohexanone%20%28BHMC%29%20on%204T1%20breast%20cancer%20cells.pdf http://psasir.upm.edu.my/id/eprint/63554/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The In Vivo Anti-Tumor Effect of Curcumin Derivative (2E,6E)-2,6-bis(4-hydroxy-3-methoxybenzylidene) Cyclohexanone (BHMC) on 4T1 Breast Cancer Cells
by: Nursyamirah, Abd Razak, et al.
Published: (2017) -
Induction of apoptosis and regulation of MicroRNA expression by (2E,6E)-2,6-bis-(4-hydroxy-3-methoxybenzylidene)-cyclohexanone (BHMC) treatment on MCF-7 breast cancer cells
by: Yeap, Swee Keong, et al.
Published: (2021) -
Cytotoxic effect of 2,6-bis(4-hydroxy-3-methoxybenzylidene) cyclohexanone (BHMC) and curcumin on human liver cancer cells, HepG2
by: Syed Alwi, Sharifah Sakinah, et al.
Published: (2019) -
Development and validation of a bioanalytical method for quantification of 2,6-bis-(4-hydroxy-3-methoxybenzylidene)-cyclohexanone (BHMC) in rat plasma
by: Lee, Yu Zhao, et al.
Published: (2012) -
Induction of apoptosis and regulation ofMicroRNA expression by (2E,6E)-2,6-bis-(4-hydroxy-3-methoxybenzylidene)- cyclohexanone (BHMC) treatment on MCF-7 breast cancer cells
by: Yeap, S. K., et al.
Published: (2021)